Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Infectious Diseases

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/510677PMID 17205448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

  2007cited by this paper
• A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

  2006cited by this paper
• Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

  2006cited by this paper
• Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial

  2006cited by this paper
• Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

  2006cited by this paper
• Multicenter clinical evaluation of the (1→3)β-D-glucan assay as an aid to diagnosis of fungal infections in humans: Ostrosky-Zeichner L, Alexander BD, Kett DH, et al: Clin Infect Dis 41 (5) : 654-659, 2005

  2006cited by this paper
• Posaconazole as Salvage Therapy for Zygomycosis

  2006cited by this paper
• Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study

  2006cited by this paper
• Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

  2005cited by this paper
• Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.

  2005cited by this paper
• Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.

  2005cited by this paper
• Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results of a Randomized, Multicenter Trial.

  2005cited by this paper
• Posaconazole: a broad-spectrum triazole antifungal.

  2005cited by this paper
• Activity of posaconazole in the treatment of central nervous system fungal infections.

  2005cited by this paper
• Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

  2005cited by this paper
• Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics

  2005cited by this paper
• Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

  2005cited by this paper
• Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction

  2004cited by this paper
• Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

  2004cited by this paper
• Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

  2004cited by this paper
• Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

  2004cited by this paper
• Fusarium infection in hematopoietic stem cell transplant recipients.

  2004cited by this paper
• Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

  2004cited by this paper
• Chapter 58 – Fever and Neutropenia

  2004cited by this paper
• β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

  2004cited by this paper
• Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.

  2004cited by this paper
• Outcome Determinants of Fusariosis in a Tertiary Care Cancer Center: The Impact of Neutrophil Recovery

  2004cited by this paper
• Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

  2004cited by this paper
• Infections due to emerging and uncommon medically important fungal pathogens.

  2004cited by this paper
• Cyclophosphamide metabolism is affected by azole antifungals.

  2004cited by this paper
• Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.

  2004cited by this paper
• Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.

  2004cited by this paper
• Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

  2004cited by this paper
• Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

  2004cited by this paper
• Antifungal therapy for febrile neutropenia: issues in clinical trial design.

  2004cited by this paper
• Rapid diagnosis of invasive aspergillosis by antigen detection

  2003cited by this paper
• Mortality and cancer incidence among individuals with Down syndrome.

  2003cited by this paper
• Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

  2003cited by this paper
• In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

  2003cited by this paper
• False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

  2003cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

  2003influential reference
• Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

  2002influential reference
• Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• In Vitro and In Vivo Activities of Posaconazole against Coccidioides immitis

  2002cited by this paper
• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

  2002cited by this paper
• Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

  2002cited by this paper
• Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

  2002cited by this paper
• Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

  2002cited by this paper
• Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients.

  2002cited by this paper
• Antifungal prophylaxis for severely neutropenic chemotherapy recipients

  2002cited by this paper
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

  2002cited by this paper
• Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

  2002cited by this paper
• Invasive mold infections in allogeneic bone marrow transplant recipients.

  2001cited by this paper
• Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia

  2001cited by this paper
• In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. andCryptococcus neoformans

  2001cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy

  2001cited by this paper
• A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.

  2000cited by this paper
• In Vitro Susceptibility Testing of Filamentous Fungi: Comparison of Etest and Reference Microdilution Methods for Determining Itraconazole MICs

  2000cited by this paper
• Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

  2000cited by this paper
• Prophylactic action of oral fluconazole against fungal infection in neutropenic patients

  2000cited by this paper
• Randomized Placebo-Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy

  1999cited by this paper
• Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.

  1999cited by this paper
• Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

  1999cited by this paper
• Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

  1999cited by this paper
• The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

  1998cited by this paper
• Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.

  1997cited by this paper
• Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

  1997cited by this paper
• Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

  1997cited by this paper
• Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

  1997cited by this paper
• Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

  1996cited by this paper
• Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

  1995cited by this paper
• Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B

  1994cited by this paper
• Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

  1993cited by this paper
• A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

  1992cited by this paper
• Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.

  1989cited by this paper
• Empirical antifungal therapy in febrile granulocytopenic patients

  1989cited by this paper
• Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

  1982cited by this paper
• Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

  1977cited by this paper
• CAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA

  1976cited by this paper
• Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

  1971cited by this paper

• Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi

  2026cites this paper
• Vaccines preventing neonatal sepsis: focus on group B Streptococcus, Klebsiella pneumoniae and Escherichia coli to combat rising antimicrobial resistance.

  2026cites this paper
• Navigating Trichosporon Asahii Infections in Pediatric Leukemia: First Reported Case in Central and Eastern Europe Case Report and Literature Review

  2025cites this paper
• Epidemiology and risk factors of invasive pulmonary fungal disease in patients with lung cancer.

  2025cites this paper
• The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections

  2024cites this paper
• The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections

  2024cites this paper
• Neonatal sepsis: A review of current management strategies

  2024cites this paper
• The Effects of Two Kinds of Gargles on Oral Mucositis in Patients After Allogeneic Stem Cell Transplantation.

  2024cites this paper
• The Triple Crown: NO, CO, and H2S in cancer cell biology.

  2023cites this paper
• Invasive fungal infection in ANCA-associated vasculitis: Between the Devil and Deep blue sea. Case series and review of the literature

  2023cites this paper
• Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis

  2022cites this paper
• Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification

  2022cites this paper
• The Value of Nasal and Oral Clinical Examination in Febrile Neutropenic Patients for Initiating Antifungal Therapy as a Preemptive Method

  2022cites this paper
• Role of the innate immune system in host defence against fungal infections.

  2022cites this paper
• Oncological Critical Care Considerations in Children

  2021cites this paper
• Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

  2021cites this paper
• Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal

  2020cites this paper
• Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β-d-Glucan Assay

  2020cites this paper
• Prospektive Kohortenstudie zur Erfassung und Evaluation von febriler Neutropenie, Infektherden und antimikrobieller Therapie bei Patienten mit Lymphomen

  2019cites this paper
• Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016

  2019influential citation
• Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy

  2019cites this paper
• Common symptoms at CKD ( Chronic Kidney Disease )

  2018cites this paper
• 96 – Infections in Hematopoietic Stem Cell Transplant Recipients

  2018cites this paper
• Medical Course and Complications After Hematopoietic Cell Transplantation

  2018cites this paper
• BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS

  2018cites this paper
• Silver-coated gold nanorods as a promising antimicrobial agent in the treatment of cancer-related infections

  2018cites this paper
• Pyogranulomatous obliterative laryngotracheitis by Rhizopus arrhizus (syn. R. oryzae) in a free-ranging Atlantic spotted dolphin Stenella frontalis.

  2018cites this paper
• Advances in treatment formulations for acute myeloid leukemia.

  2018cites this paper
• Antifungal prophylaxis in newly diagnosed AML patients–Adherence to guidelines and feasibility in a real life setting

  2017cites this paper
• High Frequencies of Drug-resistant Pathogens in Blood Stream Infections Associated with Hematologic Disorders: Five-year single institutional surveillance from 2010 to 2014

  2017cites this paper
• Infections en hématologie. Neutropénies fébriles et infections bactériennes

  2017cites this paper
• Clinical Infectious Diseases

  2017cites this paper
• Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China

  2016cites this paper
• ANtifungal Prophylaxis: An Ounce of Prevention is Worth a Pound of Cure

  2016cites this paper
• Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant

  2016cites this paper
• Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections

  2016cites this paper
• Synthesis and characterization of caffeic acid and dihydrocaffeic acid derivatives as antifungal agents

  2016influential citation
• Antifungal effect and action mechanism of antimicrobial peptide polybia‐CP

  2016cites this paper
• Cinnamaldehyde and its derivatives, a novel class of antifungal agents.

  2016cites this paper
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

  2016cites this paper
• A Systematic Review of Invasive Fungal Infection Treatment With Voriconazole And Caspofungin Among Chinese Population

  2015cites this paper
• Aspects of Renal Disease Affecting Dental Management — Surgery in Patients Receiving Hemodyalisis

  2015cites this paper
• Place du sérodiagnostic dans les infections fongiques invasives à Candida. Enquête sur la prescription des sérologies Candida au CHU de Nancy et comparaison de deux kits commerciaux ELISA pour la détection des antigènes mannanes et anticorps anti-mannanes

  2015cites this paper
• Invasive fungal infections: What to do if there's a fungus among us among us

  2015cites this paper
• Pharmacokinetic evaluation of liposomal amphotericin B (L-AMB) in patients with invasive fungal infection: Population approach in Japanese pediatrics.

  2015cites this paper
• Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

  2014cites this paper
• Hematopoietic Stem Cell Transplantation in the PICU

  2014cites this paper
• Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update

  2014cites this paper
• Management of invasive fungal infections in the pediatric intensive care unit

  2014cites this paper
• Prevention of infection in cancer patients.

  2014cites this paper
• Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

  2014cites this paper
• Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

  2014cites this paper
• Respiratory Infections

  2014cites this paper
• Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients

  2014cites this paper
• ASSESSMENT OF β-D-(1→3)-GLUCAN ASSAY FOR DIAGNOSIS OF INVASIVE FUNGAL INFEC- TIONS

  2014cites this paper
• Yield of fungal surveillance cultures in pediatric hematopoietic stem cell transplant patients: a retrospective analysis and survey of current practice.

  2014cites this paper
• Adhesive properties of Aspergillus fumigatus biofilms probed by atomic force microscopy and effects of alginate lyase enzyme

  2014cites this paper
• Combat-Related Invasive Fungal Wound Infections

  2014cites this paper
• Evaluation of treatment of invasive fungal infections

  2014cites this paper
• Re-imagining the surveillance of invasive mould diseases

  2014cites this paper
• Management of Chemotherapy-Induced Neutropenic Fever

  2013cites this paper
• Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

  2013cites this paper
• Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B

  2013cites this paper
• The Prevalence of Antifungal Agents Administration in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study

  2013influential citation
• Advances in critical care of the pediatric hematopoietic stem cell transplant patient.

  2013cites this paper
• Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review

  2013cites this paper
• Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.

  2013cites this paper
• Reduction in the Risk Invasive Fungal Infection Relapse in Patients Undergoing Allogenic Stem Cell Transplantation Using Caspofunginas Secondary Prophylaxis

  2013cites this paper
• Evaluation and Management of Bacterial and Fungal Infections Occurring in Patients with a Hematological Malignancy: A 2011 Update

  2012influential citation
• Two Rare Cases Of Central Nervous System Opportunistic Mycoses / Oportunističke Mikoze Središnjega Živčanog Sustava – Prikaz Dvaju Bolesnika

  2012cites this paper
• In Vitro Interaction between Alginate Lyase and Amphotericin B against Aspergillus fumigatus Biofilm Determined by Different Methods

  2012cites this paper
• (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs)

  2012cites this paper
• Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine

  2012cites this paper
• Early implementation of antifungal therapy in the management of febrile neutropenia is associated with favourable outcome during induction chemotherapy for acute leukaemias

  2012cites this paper
• Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.

  2012cites this paper
• Prevention and treatment of cancer-related infections.

  2012cites this paper
• Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies.

  2012cites this paper
• A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).

  2011cites this paper
• Epidemiology of Systemic Fungal Diseases: An Overview

  2011cites this paper
• β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

  2011cites this paper
• Does high-resolution CT has diagnostic value in patients presenting with respiratory symptoms after hematopoietic stem cell transplantation?

  2011cites this paper
• Antibacterial, Antifungal, and Antiviral Prophylaxis in High-Risk Cancer and Stem Cell Transplant Population

  2011cites this paper
• Invasive Fungal Infections in Patients with Acute Leukemia and Hematopoietic Stem Cell Transplant Recipients

  2011cites this paper
• Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies?

  2011cites this paper
• Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?

  2011cites this paper
• Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

  2011cites this paper
• Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).

  2011cites this paper
• The value of amphotericin B in the treatment of invasive fungal infections.

  2011cites this paper
• Current evidence for the treatment of invasive fungal infections in immunocompromised patients

  2011cites this paper
• Treatment of invasive aspergillosis in cancer patients

  2011cites this paper
• Invasive fungal infections in acute leukemia

  2011cites this paper
• Positive results of serum galactomannan assays and pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

  2011cites this paper
• Fungal Infections in Neutropenic Patients

  2011cites this paper
• The use of antimicrobial agents in children with fever during chemotherapy-induced neutropenia: the importance of risk stratification.

  2011cites this paper
• Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.

  2011cites this paper
• Organ Toxicity of Cancer Chemotherapy

  2011cites this paper
• Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation

  2011cites this paper
• Controversies in Antimicrobial Stewardship

  2011cites this paper
• Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

  2011cites this paper
• Ultrashort Peptide Bioconjugates Are Exclusively Antifungal Agents and Synergize with Cyclodextrin and Amphotericin B

  2011cites this paper